173 related articles for article (PubMed ID: 36326189)
1. Method for Calculating the Simultaneous Maximum Acceptable Risk Threshold (SMART) from Discrete-Choice Experiment Benefit-Risk Studies.
Fairchild AO; Reed SD; Gonzalez JM
Med Decis Making; 2023 Feb; 43(2):227-238. PubMed ID: 36326189
[TBL] [Abstract][Full Text] [Related]
2. Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions.
Montano-Campos JF; Gonzalez JM; Rickert T; Fairchild AO; Levitan B; Reed SD
MDM Policy Pract; 2023; 8(1):23814683221148715. PubMed ID: 36654678
[TBL] [Abstract][Full Text] [Related]
3. Eliciting benefit-risk preferences and probability-weighted utility using choice-format conjoint analysis.
Van Houtven G; Johnson FR; Kilambi V; Hauber AB
Med Decis Making; 2011; 31(3):469-80. PubMed ID: 21310854
[TBL] [Abstract][Full Text] [Related]
4. The Impact of the Risk Functional Form Assumptions on Maximum Acceptable Risk Measures.
Gonzalez JM; Boeri M
Patient; 2021 Nov; 14(6):827-836. PubMed ID: 33961275
[TBL] [Abstract][Full Text] [Related]
5. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.
Gonzalez JM
Patient; 2018 Jun; 11(3):285-300. PubMed ID: 29332301
[TBL] [Abstract][Full Text] [Related]
7. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
Brett Hauber A; Fairchild AO; Reed Johnson F
Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
[TBL] [Abstract][Full Text] [Related]
8. Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.
von Arx LB; Johnson FR; Mørkbak MR; Kjær T
Value Health; 2017 Apr; 20(4):670-678. PubMed ID: 28408010
[TBL] [Abstract][Full Text] [Related]
9. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.
Menges D; Piatti MC; Omlin A; Cathomas R; Benamran D; Fischer S; Iselin C; Küng M; Lorch A; Prause L; Rothermundt C; O'Meara Stern A; Zihler D; Lippuner M; Braun J; Cerny T; Puhan MA
Eur Urol Open Sci; 2023 May; 51():26-38. PubMed ID: 37187724
[TBL] [Abstract][Full Text] [Related]
10. Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique.
Veldwijk J; DiSantostefano RL; Janssen E; Simons G; Englbrecht M; Schölin Bywall K; Radawski C; Raza K; Hauber B; Falahee M
Patient; 2023 Nov; 16(6):641-653. PubMed ID: 37647010
[TBL] [Abstract][Full Text] [Related]
11. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event.
Bridges JFP; Tsai JH; Janssen E; Crossnohere NL; Fischer R; Peay H
Patient; 2019 Apr; 12(2):247-257. PubMed ID: 30259384
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences for mitral valve regurgitation treatment: a discrete choice experiment.
Janssen E; Keuffel EL; Liden B; Hanna A; Rizzo JA
Postgrad Med; 2022 Mar; 134(2):125-142. PubMed ID: 34981982
[TBL] [Abstract][Full Text] [Related]
13. Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
Vass CM; Payne K
Pharmacoeconomics; 2017 Sep; 35(9):859-866. PubMed ID: 28536955
[TBL] [Abstract][Full Text] [Related]
14. Quantifying Benefit-Risk Preferences for Heart Failure Devices: A Stated-Preference Study.
Reed SD; Yang JC; Rickert T; Johnson FR; Gonzalez JM; Mentz RJ; Krucoff MW; Vemulapalli S; Adamson PB; Gebben DJ; Rincon-Gonzalez L; Saha A; Schaber D; Stein KM; Tarver ME; Bruhn-Ding D
Circ Heart Fail; 2022 Jan; 15(1):e008797. PubMed ID: 34937393
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment.
Hazlewood GS; Pokharel G; Deardon R; Marshall DA; Bombardier C; Tomlinson G; Ma C; Seow CH; Panaccione R; Kaplan GG
PLoS One; 2020; 15(1):e0227635. PubMed ID: 31945089
[TBL] [Abstract][Full Text] [Related]
16. Physician-Specific Maximum Acceptable Risk in Personalized Medicine: Implications for Medical Decision Making.
Boeri M; McMichael AJ; Kane JPM; O'Neill FA; Kee F
Med Decis Making; 2018 Jul; 38(5):593-600. PubMed ID: 29611459
[TBL] [Abstract][Full Text] [Related]
17. From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs.
Tervonen T; Pignatti F; Postmus D
Med Decis Making; 2019 Oct; 39(7):879-885. PubMed ID: 31496357
[No Abstract] [Full Text] [Related]
18. Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment.
Livingstone A; Howard K; Menzies AM; Long GV; Stockler MR; Morton RL
Patient; 2023 Sep; 16(5):497-513. PubMed ID: 37351797
[TBL] [Abstract][Full Text] [Related]
19. Do patients prefer mesh or anterior colporrhaphy for primary correction of anterior vaginal wall prolapse: a labelled discrete choice experiment.
Notten K; Essers BA; Weemhoff M; Rutten A; Donners J; van Gestel I; Kruitwagen R; Roovers J; Dirksen CD
BJOG; 2015 May; 122(6):873-880. PubMed ID: 25041082
[TBL] [Abstract][Full Text] [Related]
20. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
Simons G; Veldwijk J; DiSantostefano RL; Englbrecht M; Radawski C; Bywall KS; Valor Méndez L; Hauber B; Raza K; Falahee M
Rheumatology (Oxford); 2023 Feb; 62(2):596-605. PubMed ID: 36068022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
